Literature DB >> 15780179

Residues Met76 and Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition.

Wei Hua Yan1, Li An Fan.   

Abstract

Human leukocyte antigen-G (HLA-G) has long been speculated as a beneficial factor for a successful pregnancy for its restricted expression on fetal-maternal extravillous cytotrophoblasts and its capability of modulating uterine natural killer cell (uNK) function such as cytotoxicity and cytokine production through NK cell receptors. HLA class I alpha1 domain is an important killer cell Ig-like receptor (KIR) recognition site and the Met76 and Gln79 are unique to HLA-G in this region. NK cell receptor KIR2DL4 is a specific receptor for HLA-G, yet the recognition site on HLA-G remains unknown. In this study, retroviral transduction was applied to express the wild type HLA-G (HLA-wtG), mutant HLA-G (HLA-mG) on the chronic myelogenous leukemia cell line K562 cells and KIR2DL4 molecule on NK-92 cells, respectively. KIR2DL4-IgG Fc fusion protein was generated to determine the binding specificity between KIR2DL4 and HLA-G. Our results showed that residue Met76, Gln79 mutated to Ala76,79 in the alpha1 domain of HLA-G protein could affect the binding affinity between KIR2DL4 and HLA-G, meanwhile, the KIR2DL4 transfected NK-92 cells (NK-92-2DL4) showed a considerably different cytolysis ability against the HLA-wtG and HLA-mG transfected K562 targets. Taken together, our data indicated that residue Met76 and Gln79 in HLA-G alpha1 domain plays a critical role in the recognition of KIR2DL4, which could be an explanation for the isoforms of HLA-G, all containing the a1 domain, with the potential to regulate NK functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15780179     DOI: 10.1038/sj.cr.7290283

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  26 in total

Review 1.  The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells.

Authors:  Roberta Rizzo; Martine Vercammen; Hilde van de Velde; Peter A Horn; Vera Rebmann
Journal:  Cell Mol Life Sci       Date:  2010-11-16       Impact factor: 9.261

2.  Soluble HLA-G induces NF-kappaB activation in natural killer cells.

Authors:  I Zidi; C Guillard; E D Carosella; P Moreau
Journal:  J Physiol Biochem       Date:  2010-04-20       Impact factor: 4.158

Review 3.  Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?

Authors:  Laurence Amiot; Soldano Ferrone; Hans Grosse-Wilde; Barbara Seliger
Journal:  Cell Mol Life Sci       Date:  2010-11-10       Impact factor: 9.261

4.  The structure and stability of the monomorphic HLA-G are influenced by the nature of the bound peptide.

Authors:  Nicholas G Walpole; Lars Kjer-Nielsen; Lyudmila Kostenko; James McCluskey; Andrew G Brooks; Jamie Rossjohn; Craig S Clements
Journal:  J Mol Biol       Date:  2010-02-01       Impact factor: 5.469

5.  Differentially Expressed Bone Marrow microRNAs Are Associated With Soluble HLA-G Bone Marrow Levels in Childhood Leukemia.

Authors:  Renata Santos Almeida; Thailany Thays Gomes; Felipe Souza Araújo; Sávio Augusto Vieira de Oliveira; Jair Figueredo Santos; Eduardo Antônio Donadi; Norma Lucena-Silva
Journal:  Front Genet       Date:  2022-06-14       Impact factor: 4.772

6.  Expression of HLA-G in hemangioma and its clinical significance.

Authors:  Guang Shan; Tian Tang; Duanlian Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-10-18

7.  Characterization of cynomolgus and vervet monkey placental MHC class I expression: diversity of the nonhuman primate AG locus.

Authors:  Gennadiy I Bondarenko; Svetlana V Dambaeva; Richard L Grendell; Austin L Hughes; Maureen Durning; Mark A Garthwaite; Thaddeus G Golos
Journal:  Immunogenetics       Date:  2009-05-26       Impact factor: 2.846

Review 8.  Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association.

Authors:  Eduardo A Donadi; Erick C Castelli; Antonio Arnaiz-Villena; Michel Roger; Diego Rey; Philippe Moreau
Journal:  Cell Mol Life Sci       Date:  2010-11-24       Impact factor: 9.261

9.  Comprehensive Transcriptomic Analysis Reveals the Role of the Immune Checkpoint HLA-G Molecule in Cancers.

Authors:  Hui-Hui Xu; Jun Gan; Dan-Ping Xu; Lu Li; Wei-Hua Yan
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

Review 10.  Immune modulation of HLA-G dimer in maternal-fetal interface.

Authors:  Kimiko Kuroki; Katsumi Maenaka
Journal:  Eur J Immunol       Date:  2007-07       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.